Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that is in Phase 2a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington. Show More...
-
Website http://www.cocrystalpharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.71 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.3 -3.3 -3.9 -2.1 -0.3 -2.4 -3.3 -0.03 -1.75 -1.51 -1.66 Dividends USD Payout Ratio % * Shares Mil 1.0 2.0 2.0 2.0 11.0 21.0 24.0 24.0 28.0 32.0 35.0 Book Value Per Share * USD -0.1 -1.7 -2.75 0.97 8.5 7.05 4.12 3.7 2.01 0.78 Free Cash Flow Per Share * USD 0.34 -0.88 -0.36 -1.46 -0.4 -0.67 -0.32 -0.3 -0.08 Return on Assets % -48.02 -142.94 -107.73 -346.93 -1.75 -20.73 -44.39 -0.5 -51.63 -99.22 -89.2 Financial Leverage (Average) 8.54 38.98 1.34 1.22 1.15 1.02 1.11 1.06 Return on Equity % -143.41 -744.86 -57.53 -57.41 -0.59 -56.94 -104.04 -93.01 Return on Invested Capital % -143.41 -765.14 -57.69 -57.48 -0.58 -56.43 -102.73 -91.53 Interest Coverage -3.39 -0.45 -2.48 Current Ratio 0.28 0.4 0.34 0.52 0.7 1.48 2.68 1.55 1.89 3.62 11.73 Quick Ratio 0.28 0.13 0.11 0.05 0.68 1.41 2.43 1.45 1.75 3.53 11.6 Debt/Equity 0.010 0.02 0.010